Biggest changeThe $6.9 million increase was the result of $4.9 million of interest income, $2.2 million of Employee Retention Credits and a $(0.2) million net impact of capitalized interest relating to our Convertible Note in the comparable period in 2022. 75 Year ended December 31, 2022 compared to year ended December 31, 2021 The following tables set forth our results of operations for the periods presented: Year Ended December 31, Year Ended December 31, 2022 2021 $ Change % Change 2022 2021 ($ in thousands) (Percentage of total revenue) Revenue $ 180,364 $ 121,622 $ 58,742 48% 100% 100% Cost of revenue 175,388 111,685 63,703 57% 97% 92% Gross profit 4,976 9,937 (4,961 ) (50)% 3% 8% Operating expenses Research and development 16,930 11,441 5,489 48% 9% 9% Sales and marketing 28,792 16,581 12,211 74% 16% 14% General and administrative 38,499 22,514 15,985 71% 21% 19% Total operating expenses 84,221 50,536 33,685 67% 47% 42% Loss from operations (79,245 ) (40,599 ) (38,646 ) 95% (44)% (33)% Other income (expense) Interest expense, convertible note - related party (5,110 ) — (5,110 ) 100% (3)% 0% Interest income (expense), net 1,617 (229 ) 1,846 (806)% 1% 0% Gain on extinguishment of debt — 3,734 (3,734 ) 100% —% 3% Total other income (expense) (3,493 ) 3,505 (6,998 ) (200)% (2)% 3% Net loss $ (82,738 ) $ (37,094 ) $ (45,644 ) (123)% (46)% (30)% Revenue Year Ended December 31, Change 2022 2021 Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage ($ in thousands) Revenue: Energy industrial $ 124,807 69% $ 114,958 95% $ 9,849 9% Thermal barrier 55,557 31% 6,664 5% 48,893 NM Total revenue $ 180,364 100% $ 121,622 100% $ 58,742 48% The following chart sets forth product shipments in square feet associated with recognized revenue, including revenue recognized over time, for the periods presented: Year Ended December 31, Change 2022 2021 Amount Percentage Product shipments in square feet (in thousands) 32,589 34,557 (1,968 ) (6)% Total revenue increased $58.7 million, or 48%, to $180.3 million in 2022 from $121.6 million in 2021.
Biggest changeNet operating losses of $159.0 million generated from 2018 through 2023 have an unlimited carryforward . 70 Results of Operations The following tables set forth our results of operations for the periods presented: Year Ended December 31, 2024 2023 2022 ($ in thousands) Revenue $ 452,699 $ 238,718 $ 180,364 Cost of revenue 269,802 181,797 175,388 Gross profit 182,897 56,921 4,976 Operating expenses Research and development 18,050 16,356 16,930 Sales and marketing 35,677 33,008 28,792 General and administrative 71,125 56,760 38,499 Impairment of equipment under development 3,510 — — Total operating expenses 128,362 106,124 84,221 Income (loss) from operations 54,535 (49,203 ) (79,245 ) Other income (expense) Interest expense, convertible note - related party (7,550 ) (5,328 ) (5,110 ) Interest income (expense), net (4,409 ) 6,534 1,617 Loss on extinguishment of debt (27,487 ) — — Income from Employee Retention Credits — 2,186 — Total other income (expense) (39,446 ) 3,392 (3,493 ) Income tax expense (1,714 ) — — Net income (loss) $ 13,375 $ (45,811 ) $ (82,738 ) Year ended December 31, 2024 compared to year ended December 31, 2023 The following tables set forth our results of operations for the periods presented: Year Ended December 31, Year Ended December 31, 2024 2023 $ Change % Change 2024 2023 ($ in thousands) (Percentage of total revenue) Revenue $ 452,699 $ 238,718 $ 213,981 90 % 100 % 100 % Cost of revenue 269,802 181,797 88,005 48 % 60 % 76 % Gross profit 182,897 56,921 125,976 221 % 40 % 24 % Operating expenses Research and development 18,050 16,356 1,694 10 % 4 % 7 % Sales and marketing 35,677 33,008 2,669 8 % 8 % 14 % General and administrative 71,125 56,760 14,365 25 % 16 % 24 % Impairment of equipment under development 3,510 — 3,510 NM 1 % 0 % Total operating expenses 128,362 106,124 22,238 21 % 28 % 44 % Income (loss) from operations 54,535 (49,203 ) 103,738 (211 )% 12 % (21 )% Other income (expense) Interest expense, convertible note - related party (7,550 ) (5,328 ) (2,222 ) 42 % (2 )% (2 )% Interest income, net (4,409 ) 6,534 (10,943 ) (167 )% (1 )% 3 % Loss on extinguishment of debt (27,487 ) — (27,487 ) NM (6 )% 0 % Income from Employee Retention Credits — 2,186 (2,186 ) (100 )% — % 1 % Total other income (expense) (39,446 ) 3,392 (42,838 ) (1,263 )% (9 )% 1 % Income tax expense (1,714 ) — (1,714 ) NM (0 )% (— )% Net income (loss) $ 13,375 $ (45,811 ) $ 59,186 129 % 3 % (19 )% 71 Revenue Year Ended December 31, 2024 2023 Change Percentage of Percentage of Amount Revenue Amount Revenue Amount Percentage ($ in thousands) Revenue: Energy industrial $ 145,867 32% $ 128,639 54% $ 17,228 13% Thermal barrier 306,832 68% 110,079 46% 196,753 179% Total revenue $ 452,699 100% $ 238,718 100% $ 213,981 90% Total revenue increased $214.0 million, or 90%, to $452.7 million in 2024 from $238.7 million in 2023.
Cost of Revenue Year Ended December 31, 2023 2022 Change % of Related % of Related Amount Revenue Amount Revenue Amount Percentage ($ in thousands) Cost of revenue: Energy industrial $ 94,477 73% $ 105,963 85% $ (11,486 ) (11)% Thermal barrier 87,320 79% 69,425 125% 17,895 26% Total cost of revenue $ 181,797 76% $ 175,388 97% $ 6,409 4% Total cost of revenue increased $6.4 million, or 4%, to $181.8 million in 2023 from $175.4 million in 2022.
Cost of Revenue Year Ended December 31, Change 2023 2022 Amount Percentage of Related Revenue Amount Percentage of Related Revenue Amount Percentage ($ in thousands) Cost of revenue: Energy industrial $ 94,477 73% $ 105,963 85% $ (11,486 ) (11)% Thermal barrier 87,320 79% 69,425 125% 17,895 26% Total cost of revenue $ 181,797 76% $ 175,388 97% $ 6,409 4% Total cost of revenue increased $6.4 million, or 4%, to $181.8 million in 2023 from $175.4 million in 2022.
Financing Activities Net cash provided by financing activities in 2023 totaled $75.5 million and consisted of net proceeds from the registered direct offering of common stock of $74.2 million and $1.7 million in proceeds from employee stock option exercises, offset, in part, by $0.4 million in cash used for payments made for employee tax withholdings associated with the vesting of restricted stock units.
Net cash provided by financing activities in 2023 totaled $75.5 million and consisted of net proceeds from the registered direct offering of common stock of $74.2 million and $1.7 million in proceeds from employee stock option exercises, offset, in part, by $0.4 million in cash used for payments made for employee tax withholdings associated with the vesting of restricted stock units.
Some of these limitations are: • Adjusted EBITDA does not reflect our historical cash expenditures or future requirements for capital expenditures or other contractual commitments; • Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; • Adjusted EBITDA does not reflect stock-based compensation expense; 67 • Adjusted EBITDA does not reflect our income tax expense or cash requirements to pay our income taxes; • Adjusted EBITDA does not reflect our interest expense, or the cash requirements necessary to service interest or principal payments on our debt; • although depreciation, amortization and impairment charges are non-cash charges, the assets being depreciated, amortized or impaired will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for these replacements; and • other companies in our industry may calculate EBITDA or Adjusted EBITDA differently than we do, limiting their usefulness as a comparative measure.
Some of these limitations are: • Adjusted EBITDA does not reflect our historical cash expenditures or future requirements for capital expenditures or other contractual commitments; • Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; • Adjusted EBITDA does not reflect stock-based compensation expense; • Adjusted EBITDA does not reflect our income tax expense or cash requirements to pay our income taxes; • Adjusted EBITDA does not reflect our interest expense, or the cash requirements necessary to service interest or principal payments on our debt; • although depreciation, amortization and impairment charges are non-cash charges, the assets being depreciated, amortized or impaired will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for these replacements; and • other companies in our industry may calculate EBITDA or Adjusted EBITDA differently than we do, limiting their usefulness as a comparative measure.
See note 2 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for information about these critical accounting policies, as well as a description of our other significant accounting policies. 83 Revenue Recognition We recognize revenue from the sale of our energy industrial aerogel products and thermal barriers.
See note 2 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for information about these critical accounting policies, as well as a description of our other significant accounting policies. Revenue Recognition We recognize revenue from the sale of our energy industrial aerogel products and thermal barriers.
We based the simulation model on the Black Scholes option-pricing model and a number of other complex assumptions including (i) whether the vesting condition would be satisfied within the time-vesting periods, and (ii) the date the common stock price target would be achieved per the terms of the agreement.
We based the simulation model on the Black Scholes option-pricing model and a number of other complex assumptions including (i) whether the vesting condition would be satisfied within the time-vesting periods, and (ii) the date the common stock price target would be achieved per the terms of the agreement. 83
GAAP financial statements included elsewhere in this Annual Report on Form 10-K, and not to rely on any single financial measure to evaluate our business. The following table presents a reconciliation of net loss, the most directly comparable U.S.
GAAP financial statements included elsewhere in this Annual Report on Form 10-K, and not to rely on any single financial measure to evaluate our business. 66 The following table presents a reconciliation of net loss, the most directly comparable U.S.
Research and Development Expenses Year Ended December 31, Change 2023 2022 Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage ($ in thousands) Research and development expenses $ 16,356 7% $ 16,930 9% $ (574 ) (3)% Research and development expenses decreased by $0.5 million, or 3%, to $16.4 million in 2023 from $16.9 million in 2022.
Research and Development Expenses Year Ended December 31, Change 2023 2022 Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage ($ in thousands) Research and development expenses $ 16,356 7% $ 16,930 9% $ (574 ) (3)% 76 Research and development expenses decreased by $0.5 million, or 3%, to $16.4 million in 2023 from $16.9 million in 2022.
This increase was driven by a more favorable mix of product shipments in the global petrochemical and refinery markets, particularly in Asia and North America, project-based demand in the subsea market, offset, in part, by a decrease in maintenance-based demand in the global petrochemical and refinery markets in Europe.
This increase was driven by a more favorable mix of product shipments in the global petrochemical and refinery markets, particularly in North America, Latin America, and Europe, offset, in part, by a decrease in maintenance-based demand in the global petrochemical and refinery markets in Asia and project-based demand in the subsea market.
While the OEM has agreed to purchase its requirement for Barriers for locations to be designated from time to time by the OEM, it has no obligation to purchase any minimum quantity of Barriers under the Contracts. In addition, the OEM may terminate the Contracts any time and for any or no reason.
While the OEM has agreed to purchase its requirement for Barriers for locations to be designated from time to time by the OEM, it has no obligation to purchase any minimum quantity of Barriers under the 80 Contracts. In addition, the OEM may terminate the Contracts any time and for any or no reason.
The increase in total cost of revenue was the result of an increase in thermal barrier, offset, in part, by a decrease in energy industrial cost of revenue. 73 Energy industrial cost of revenue decreased $11.5 million, or 11%, to $94.5 million from $106.0 million in the comparable period in 2022.
The increase in total cost of revenue was the result of an increase in thermal barrier, offset, in part, by a decrease in energy industrial cost of revenue. Energy industrial cost of revenue decreased $11.5 million, or 11%, to $94.5 million from $106.0 million in the comparable period in 2022.
Thermal barrier revenue for the year ended December 31, 2023 included $97.5 million to a major U.S. automotive OEM and $5.5 million to a major Asian automotive OEM. Thermal barrier revenue for the year ended December 31, 2022 included $45.8 million to a major U.S. automotive OEM and $5.1 million to a major Asian automotive OEM.
Thermal barrier revenue for the year ended December 31, 2023 included $97.5 million to a major U.S. 75 automotive OEM and $5.5 million to a major Asian automotive OEM. Thermal barrier revenue for the year ended December 31, 2022 included $45.8 million to a major U.S. automotive OEM and $5.1 million to a major Asian automotive OEM.
Gross Profit Year Ended December 31, 2023 2022 Change Percentage Percentage Amount of Revenue Amount of Revenue Amount Percentage ($ in thousands) Gross profit: Energy industrial $ 34,162 27% $ 18,844 15% $ 15,318 81% Thermal barrier 22,759 21% (13,868 ) (25)% 36,627 264% Total gross profit $ 56,921 24% $ 4,976 3% $ 51,945 1,044% Gross profit increased $51.9 million, or 1,044%, to $56.9 million in 2023 from $5.0 million in 2022.
Gross Profit Year Ended December 31, Change 2023 2022 Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage Gross profit: Energy industrial $ 34,162 27% $ 18,844 15% $ 15,318 81% Thermal barrier 22,759 21% (13,868 ) (25)% 36,627 (264)% Total gross profit $ 56,921 24% $ 4,976 3% $ 51,945 1044% Gross profit increased $51.9 million, or 1,044%, to $56.9 million in 2023 from $5.0 million in 2022.
However, we plan to supplement our cash balance and available credit with equity financings, debt financings, equipment leasing, sale-leaseback transactions, customer prepayments or government grant and loan programs to provide the additional capital necessary to purchase the capital equipment, construct the new facilities and complete the aerogel capacity expansions required to support our evolving commercial opportunities and strategic business initiatives.
However, we may supplement our cash balance and available credit with equity financings, debt financings, equipment leasing, sale-leaseback transactions, customer prepayments or government grant and loan programs to provide the additional capital necessary to purchase the capital equipment, construct the new facilities and complete the aerogel capacity expansions required to support our evolving commercial opportunities and strategic business initiatives.
We believe this is a better representation of the estimated life than our actual limited historical exercise behavior. • For the years ended December 31, 2023, 2022 and 2021, we used our historical volatility as a basis to estimate expected volatility in the valuation of stock options. • The risk-free interest rate is based on U.S.
We believe this is a better representation of the estimated life than our actual limited historical exercise behavior. • For the years ended December 31, 2024, 2023 and 2022, we used our historical volatility as a basis to estimate expected volatility in the valuation of stock options. • The risk-free interest rate is based on U.S.
We expect that material costs will increase in absolute dollars during 2024 due to projected growth in product shipments and contracts but remain stable as a percentage of revenue due to improved manufacturing, and fabrication yields and a favorable mix of products sold. Manufacturing expense is also a significant component of cost of revenue.
We expect that material costs will increase in absolute dollars during 2025 due to projected growth in product shipments and contracts but remain stable as a percentage of revenue due to improved manufacturing, and fabrication yields and a favorable mix of products sold. Manufacturing expense is also a significant component of cost of revenue.
Accordingly, we expect that our net income (loss), earnings per share and Adjusted EBITDA will vary from period to period. During 2023, we experienced strong volume growth in our thermal barrier products. As a result, we experienced total revenue growth of 32% during the year.
Accordingly, we expect that our net income (loss), earnings per share and Adjusted EBITDA will vary from period to period. During 2024, we experienced strong volume growth in our thermal barrier products. As a result, we experienced total revenue growth of 90% during the year.
Accordingly, we expect our gross profit to vary significantly in absolute dollars and as a percentage of revenue from period to period. Gross profit as a percentage of total revenue was 24%, 3%, and 8% for the years ended December 31, 2023, 2022 and 2021, respectively.
Accordingly, we expect our gross profit to vary significantly in absolute dollars and as a percentage of revenue from period to period. Gross profit as a percentage of total revenue was 40%, 24%, and 3% for the years ended December 31, 2024, 2023 and 2022, respectively.
These commitments relate to the enhancement of our existing production lines in our East Providence facility and our fabrication operation in Mexico, and the planned aerogel manufacturing facility in Bulloch County, Georgia and consist primarily of costs for equipment and construction.
These commitments relate to the enhancement of our existing production lines in our East Providence facility and our fabrication operation in Mexico, and the previously planned aerogel manufacturing facility in Statesboro, Georgia and consist primarily of costs for equipment and construction.
Manufacturing expense includes labor, utilities, maintenance expense, and depreciation on manufacturing assets. Manufacturing expense also includes stock-based compensation of manufacturing employees and shipping costs. Manufacturing expense as a percentage of product revenue was 40%, 46% and 44% for the years ended December 31, 2023, 2022 and 2021, respectively.
Manufacturing expense includes labor, utilities, maintenance expense, and depreciation on manufacturing assets. Manufacturing expense also includes stock-based compensation of 68 manufacturing employees and shipping costs. Manufacturing expense as a percentage of product revenue was 22%, 46% and 44% for the years ended December 31, 2024, 2023 and 2022, respectively.
Provision for Income Taxes We have incurred net losses since inception and have not recorded benefit provisions for U.S. federal income taxes or state income taxes since the tax benefits of our net losses have been offset by valuation allowances due to the uncertainty associated with the utilization of net operating loss carryforwards.
Provision for Income Taxes We have incurred net losses since inception with the exception of the year ended December 31, 2024, and have not recorded benefit provisions for U.S. federal income taxes or state income taxes since the tax benefits of our net losses have been offset by valuation allowances due to the uncertainty associated with the utilization of net operating loss carryforwards.
The following assumptions were used to estimate the fair value of the option awards: Year Ended December 31, 2023 2022 2021 Weighted-average assumptions: Expected term (in years) 6.12 5.97 5.96 Expected volatility 70.04 % 61.85 % 59.80 % Risk free rate 4.08 % 2.13 % 0.86 % Expected dividend yield — % — % — % • The expected term represents the period that our stock-based awards are expected to be outstanding and is determined using the simplified method described in ASC Topic 718, Compensation — Stock Compensation , for all grants.
The following assumptions were used to estimate the fair value of the option awards: Year Ended December 31, 2024 2023 2022 Weighted-average assumptions: Expected term (in years) 5.99 6.12 5.97 Expected volatility 75.04 % 70.04 % 61.85 % Risk free rate 4.11 % 4.08 % 2.13 % Expected dividend yield — % — % — % 82 • The expected term represents the period that our stock-based awards are expected to be outstanding and is determined using the simplified method described in ASC Topic 718, Compensation — Stock Compensation , for all grants.
On March 16, 2022, we entered into a sales agreement for an ATM offering program with Cowen and Company, LLC and Piper Sandler & Co., as our sales agents, or the 2022 ATM offering program.
Financial Summary On March 16, 2022, we entered into a sales agreement for an at-the-market offering program with Cowen and Company, LLC and Piper Sandler & Co., as our sales agents (the 2022 ATM offering program).
Our ten largest customers accounted for approximately 80% of our total revenue during the year ended December 31, 2023, and we expect that most of our revenue will continue to come from a relatively small number of customers for the foreseeable future. In 2023, sales to GM and Distribution International, Inc. represented 41% and 14% of our total revenue, respectively.
Our ten largest customers accounted for approximately 84% of our total revenue during the year ended December 31, 2024, and we expect that most of our revenue will continue to come from a relatively small number of customers for the foreseeable future. In 2024, sales to GM and Distribution International, Inc.
In the meantime, and until we ramp up construction, we expect to be able to substantially reduce our planned capital expenditures for 2024. 81 We intend to fund capital expenditures related to the expansion of capacity of our existing manufacturing facility with our existing cash balance and anticipated cash flows from operations.
In the meantime, we expect to be able to substantially reduce our planned capital expenditures for 2025. We intend to fund capital expenditures related to the expansion of capacity of our existing manufacturing facility with our existing cash balance and anticipated cash flows from operations.
Our inability to use a substantial portion of our net operating loss carryforwards would result in a higher effective tax rate and adversely affect our financial condition and results of operations. Primary Sources of Liquidity Our principal sources of liquidity are currently our cash and cash equivalents.
Our inability to use a substantial portion of our net operating loss carryforwards would result in a higher effective tax rate and adversely affect our financial condition and results of operations. Primary Sources of Liquidity Our principal sources of liquidity are currently our cash and cash equivalents, availability under the Revolving Facility, and cash generated by ongoing operations.
Capital Spending and Future Capital Requirements We have made capital expenditures primarily to develop and expand our manufacturing capacity. Our capital expenditures totaled $175.5 million in 2023, $178.0 million in 2022 and $13.8 million in 2021.
Capital Spending and Future Capital Requirements We have made capital expenditures primarily to develop and expand our manufacturing capacity. Our capital expenditures totaled $86.3 million in 2024, $175.5 million in 2023 and $178.0 million in 2022.
This decrease in the use of cash was the result of the decrease in net loss adjusted for non-cash items of $44.8 million, and a decrease in cash used by changes in working capital of $7.0 million.
This decrease in the use of cash was the result of net income adjusted for non-cash items of $108.0 million, and a decrease in cash used by changes in working capital of $19.8 million.
As of December 31, 2023, we had capital commitments of approximately $202.6 million, which included commitments for which we have entered into contracts as well as commitments authorized by our Board of Directors.
As of December 31, 2024, we had capital commitments of approximately $172.4 million, which included commitments for which we have entered into contracts as well as commitments authorized by our Board of Directors.
We are also continuing to monitor the impact of engaging one or more external manufacturing facilities in China to supply our aerogel products for the energy industrial market beginning in 2024 on our manufacturing expense and cost of product revenue.
We are also continuing to monitor the impact on our material costs, manufacturing expense, and cost of product revenue from engaging one or more external manufacturing facilities in China to supply our aerogel products.
We believe that our December 31, 2023 cash and cash equivalents balance of $139.7 million will be sufficient to support current operating requirements, current research and development activities and the initial capital expenditures required to support the evolving commercial opportunities in the EV market and other strategic business opportunities.
We believe that our December 31, 2024 cash and cash equivalents balance of $220.9 million will be sufficient to support current operating requirements, current research and development activities and the initial capital expenditures required to support the evolving commercial opportunities in the EV market and other strategic business opportunities for at least the next twelve months.
We recorded warranty expense of $0.5 million during the year ended December 31, 2023. We recorded warranty expense of $0.2 million during the year ended December 31, 2022. We recorded warranty expense of less than $0.1 million during the year ended December 31, 2021. As of December 31, 2023, we had satisfied all outstanding warranty claims.
We recorded warranty expense of $1.4 million during the year ended December 31, 2024. We recorded warranty expense of $0.5 million and $0.2 million during the years ended December 31, 2023 and 2022, respectively. As of December 31, 2024, we had satisfied all outstanding warranty claims.
We also expect that the patent enforcement actions, described in more detail under “Legal Proceedings” in Part I, Item 3 of this Annual Report on Form 10-K, if protracted, could result in significant legal expense over the medium to long-term. We expect that our general and administrative expenses will increase in absolute dollars and decrease as a percentage of revenue.
We also expect that the patent enforcement actions, described in more detail under “Legal Proceedings” in Part I, Item 3 of this Annual Report on Form 10-K, if protracted, could result in significant legal expense over the medium to long-term.
Net operating losses of $164.3 million generated from 2018 through 2023 have an unlimited carryforward . 71 Results of Operations The following tables set forth our results of operations for the periods presented: Year Ended December 31, 2023 2022 2021 ($ in thousands) Revenue $ 238,718 $ 180,364 $ 121,622 Cost of revenue 181,797 175,388 111,685 Gross profit 56,921 4,976 9,937 Operating expenses Research and development 16,356 16,930 11,441 Sales and marketing 33,008 28,792 16,581 General and administrative 56,760 38,499 22,514 Total operating expenses 106,124 84,221 50,536 Loss from operations (49,203 ) (79,245 ) (40,599 ) Other income (expense) Interest expense, convertible note - related party (5,328 ) (5,110 ) — Interest income (expense), net 6,534 1,617 (229 ) Gain on extinguishment of debt — — 3,734 Income from Employee Retention Credits 2,186 — — Total other income (expense) 3,392 (3,493 ) 3,505 Net loss $ (45,811 ) $ (82,738 ) $ (37,094 ) Year ended December 31, 2023 compared to year ended December 31, 2022 The following tables set forth our results of operations for the periods presented: Year Ended December 31, Year Ended December 31, 2023 2022 $ Change % Change 2023 2022 ($ in thousands) (Percentage of total revenue) Revenue $ 238,718 $ 180,364 $ 58,354 32 % 100 % 100 % Cost of revenue 181,797 175,388 6,409 4 % 76 % 97 % Gross profit 56,921 4,976 51,945 1,044 % 24 % 3 % Operating expenses Research and development 16,356 16,930 (574 ) (3 )% 7 % 9 % Sales and marketing 33,008 28,792 4,216 15 % 14 % 16 % General and administrative 56,760 38,499 18,261 47 % 24 % 21 % Total operating expenses 106,124 84,221 21,903 26 % 44 % 47 % Loss from operations (49,203 ) (79,245 ) 30,042 (38 )% (21 )% (44 )% Other income (expense) Interest expense, convertible note - related party (5,328 ) (5,110 ) (218 ) 100 % (2 )% -3 % Interest income, net 6,534 1,617 4,917 304 % 3 % 1 % Income from Employee Retention Credits 2,186 — 2,186 100 % 1 % — % Total other income (expense) 3,392 (3,493 ) 6,885 (197 )% 1 % (2 )% Net loss $ (45,811 ) $ (82,738 ) $ 36,927 45 % (19 )% (46 )% 72 Revenue Year Ended December 31, 2023 2022 Change Percentage of Percentage of Amount Revenue Amount Revenue Amount Percentage ($ in thousands) Revenue: Energy industrial $ 128,639 54% $ 124,807 69% $ 3,832 3% Thermal barrier 110,079 46% 55,557 31% 54,522 98% Total revenue $ 238,718 100% $ 180,364 100% $ 58,354 32% The following chart sets forth energy industrial product shipments in square feet associated with recognized revenue, including revenue recognized over time, for the periods presented: Year Ended December 31, Change 2023 2022 Amount Percentage Product shipments in square feet (in thousands) 28,392 32,589 (4,197 ) (13 )% Total revenue increased $58.3 million, or 32%, to $238.7 million in 2023 from $180.4 million in 2022.
We did not incur income tax expense for the comparable period in 2023. 74 Year ended December 31, 2023 compared to year ended December 31, 2022 The following tables set forth our results of operations for the periods presented: Year Ended December 31, Year Ended December 31, 2023 2022 $ Change % Change 2023 2022 ($ in thousands) (Percentage of total revenue) Revenue $ 238,718 $ 180,364 $ 58,354 32% 100% 100% Cost of revenue 181,797 175,388 6,409 4% 76% 97% Gross profit 56,921 4,976 51,945 1,044% 24% 3% Operating expenses Research and development 16,356 16,930 (574 ) (3)% 7% 9% Sales and marketing 33,008 28,792 4,216 15% 14% 16% General and administrative 56,760 38,499 18,261 47% 24% 21% Total operating expenses 106,124 84,221 21,903 26% 44% 47% Loss from operations (49,203 ) (79,245 ) 30,042 (38)% (21)% (44)% Other income (expense) Interest expense, convertible note - related party (5,328 ) (5,110 ) (218 ) 100% (2)% -3% Interest income (expense), net 6,534 1,617 4,917 304% 3% 1% Gain on extinguishment of debt 2,186 — 2,186 100% 1% —% Total other income (expense) 3,392 (3,493 ) 6,885 (197)% 1% (2)% Net loss $ (45,811 ) $ (82,738 ) $ 36,927 45% (19)% (46)% Revenue Year Ended December 31, Change 2023 2022 Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage ($ in thousands) Revenue: Energy industrial $ 128,639 54% $ 124,807 69% $ 3,832 3% Thermal barrier 110,079 46% 55,557 31% 54,522 98% Total revenue $ 238,718 100% $ 180,364 100% $ 58,354 32% Total revenue increased $58.3 million, or 32%, to $238.7 million in 2023 from $180.4 million in 2022.
In any particular period, the timing and extent of personnel additions or reductions, legal activities, including patent enforcement actions, marketing programs, research efforts and a range of similar activities or actions could materially affect our operating expenses, both in absolute dollars and as a percentage of revenue. 70 Research and Development Expenses Research and development expenses consist primarily of expenses for personnel engaged in the development of next generation aerogel compositions, form factors and manufacturing technologies.
In any particular period, the timing and extent of personnel additions or reductions, legal activities, including patent enforcement actions, marketing programs, research efforts and a range of similar activities or actions could materially affect our operating expenses, both in absolute dollars and as a percentage of revenue.
GAAP measure, to Adjusted EBITDA for the years presented: Year Ended December 31, 2023 2022 2021 ($ in thousands) Net loss $ (45,811 ) $ (82,738 ) $ (37,094 ) Depreciation and amortization 15,318 9,222 9,440 Stock-based compensation (1) 10,954 9,385 5,176 Gain on the extinguishment of debt — — (3,734 ) Other (income) expense (3,392 ) 3,493 229 Adjusted EBITDA $ (22,931 ) $ (60,638 ) $ (25,983 ) (1) Represents non-cash stock-based compensation related to vesting and modifications of stock option grants, vesting of restricted stock units and vesting and modification of restricted common stock.
GAAP measure, to Adjusted EBITDA for the years presented: Year Ended December 31, 2024 2023 2022 ($ in thousands) Net income (loss) $ 13,375 $ (45,811 ) $ (82,738 ) Depreciation and amortization 22,526 15,318 9,222 Stock-based compensation (1) 12,855 10,954 9,385 Other (income) expense 11,959 (3,392 ) 3,493 Loss on extinguishment of debt 27,487 — — Income tax expense 1,714 — — Adjusted EBITDA $ 89,916 $ (22,931 ) $ (60,638 ) (1) Represents non-cash stock-based compensation related to vesting and modifications of stock option grants, vesting of restricted stock units and vesting and modification of restricted common stock.
Manufacturing Operations We manufacture our products using our proprietary technology at our facility in East Providence, Rhode Island. We have operated the East Providence facility since 2008 and have increased our capacity in phases.
Manufacturing Operations We manufacture our products using our proprietary technology at our facility in East Providence, Rhode Island. We have operated the East Providence facility since 2008 and have increased our capacity in phases. During 2024, we converted our East Providence facility to support the growth of the thermal barrier program.
The following table sets forth the total revenue for the periods presented: Year Ended December 31, 2023 2022 2021 ($ in thousands) Revenue: Energy industrial $ 128,639 $ 124,807 $ 114,958 Thermal barrier 110,079 55,557 6,664 Total $ 238,718 $ 180,364 $ 121,622 Energy industrial revenue accounted for 54%, 69%, and greater than 95% of total revenue for the years ended December 31, 2023, 2022 and 2021, respectively.
The following table sets forth the total revenue for the periods presented: Year Ended December 31, 2024 2023 2021 ($ in thousands) Revenue: Energy industrial $ 145,867 $ 128,639 $ 124,807 Thermal barrier 306,832 110,079 55,557 Total $ 452,699 $ 238,718 $ 180,364 Energy industrial revenue accounted for 32%, 54%, and 69% of total revenue for the years ended December 31, 2024, 2023 and 2022, respectively.
Net cash used in investing activities for 2023 and 2022 totaled $175.5 million and $178.0 million, respectively.
Net cash used in investing activities for 2024 and 2023 totaled $86.3 million and $175.5 million, respectively.
Revenue We recognize revenue from the sale of our energy industrial aerogel products and thermal barriers. Revenue is recognized upon the satisfaction of contractual performance obligations.
We also expect to incur reduced capital expenditures during 2025. 67 Revenue We recognize revenue from the sale of our energy industrial aerogel products and thermal barriers. Revenue is recognized upon the satisfaction of contractual performance obligations.
Adjusted EBITDA is a supplemental measure of our performance that is not presented in accordance with U.S. GAAP. Adjusted EBITDA should not be considered as an alternative to net income (loss) or any other measure of financial performance calculated and presented in accordance with U.S. GAAP.
Adjusted EBITDA should not be considered as an alternative to net income (loss) or any other measure of financial performance calculated and presented in accordance with U.S. GAAP. In addition, our definition and presentation of Adjusted EBITDA may not be comparable to similarly titled measures presented by other companies.
The decrease in gross profit was the result of the $63.7 million increase in total cost of revenue, partially offset by the $58.7 million increase in total revenue.
The increase in gross profit was the result of the $214.0 million increase in total revenue, partially offset by the $88.0 million increase in total cost of revenue.
During the year ended December 31, 2022, we sold 5,241,400 shares of our common stock through the 2022 ATM offering program and received net proceeds of $72.7 million. The 2022 ATM offering program was terminated on June 20, 2023. On February 3, 2021, we entered into a supply agreement with Silbond Corporation for the purchase of certain silanes products.
During the year ended December 31, 2022, we sold 5,241,400 shares of our common stock through the 2022 ATM offering program and received net proceeds of $72.7 million. The 2022 ATM offering program was terminated on June 20, 2023.
We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, from time to time, which we do not believe are indicative of our core operating performance, which in 2021 included a gain on the extinguishment of debt.
We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, from time to time, which we do not believe are indicative of our core operating performance. Adjusted EBITDA is a supplemental measure of our performance that is not presented in accordance with U.S. GAAP.
During 2022, we used $94.4 million in net cash in operating activities, as compared to the use of $18.6 million in net cash during 2021, an increase in the use of cash of $75.8 million.
During 2023, we used $42.6 million in net cash in operating activities, as compared to the use of $94.4 million in net cash during 2022, a decrease in the use of cash of $51.8 million.
We are currently evaluating segment expense disclosures related to its annual report for fiscal year 2024. In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740) Improvements to Income Tax Disclosures that requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures.
This ASU is effective for our fiscal year 2024 and interim periods in fiscal year 2025. 81 Standards to be Implemented In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740) Improvements to Income Tax Disclosures that requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures.
Total revenue from outside of the United States, based on shipment destination, amounted to $87.7 million, or 37% of our total revenue, $66.4 million, or 37% of our total revenue, and $54.8 million, or 45% of our total revenue, in the years ended December 31, 2023, 2022 and 2021, respectively. 69 Cost of Revenue Cost of product revenue consists primarily of materials and manufacturing expense.
Total revenue from outside of the United States, based on shipment destination, amounted to $194.2 million, or 43% of our total revenue, $87.7 million, or 37% of our total revenue, and $66.4 million, or 37% of our total revenue, in the years ended December 31, 2024, 2023 and 2022, respectively.
The Loan Agreement provides for a multi-draw senior secured term loan in an aggregate principal amount of up to $100.0 million, or the Loan, available to the Borrower to draw on a delayed draw basis after January 1, 2023 to September 30, 2023, subject to certain conditions precedent to funding.
In November 2022, we entered into a loan agreement (the GM Loan Agreement) with General Motors Holdings LLC (GM), an entity affiliated with General Motors LLC, which provides for a multi-draw senior secured term loan (the GM Loan) in an aggregate principal amount of up to $100.0 million, available to the Company on a delayed draw basis beginning January 1, 2023 to September 30, 2023, subject to certain conditions precedent to funding.
Key Metrics and Non-GAAP Financial Measures We regularly review a number of metrics, including the following key metrics, to evaluate our business, measure our performance, identify trends affecting our business, formulate financial projections and make strategic decisions. Square Foot Operating Metric We price our energy industrial product and measure our shipments in square feet.
Key Metrics and Non-GAAP Financial Measures We regularly review a number of metrics, including the following key metrics, to evaluate our business, measure our performance, identify trends affecting our business, formulate financial projections and make strategic decisions. 65 Adjusted EBITDA We use Adjusted EBITDA, a non-GAAP financial measure, as a means to assess our operating performance.
The $5.5 million increase was the result of increases in compensation and related costs of $2.5 million, professional fees and materials costs of $1.1 million, equipment and lease costs of $0.9 million, depreciation expenses of $0.7 million and other research and development expenses of $0.3 million.
The $1.7 million increase was the result of increases in compensation and related costs of $1.0 million, depreciation and facility related expenses of $0.3 million, utilities expenses of $0.2 million, and other expenses of $0.2 million.
Critical Accounting Policies and Estimates Our financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of our financial statements and related disclosures requires us to make estimates, assumptions and judgments that affect the reported amount of assets, liabilities, revenue, costs and expenses and related disclosures.
The preparation of our financial statements and related disclosures requires us to make estimates, assumptions and judgments that affect the reported amount of assets, liabilities, revenue, costs and expenses and related disclosures.
Recently Issued Accounting Standards From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date.
Purchase obligations are entered into with various vendors in the normal course of business and are consistent with our expected requirements. Recently Issued Accounting Standards From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies. Recently issued standards typically do not require adoption until a future effective date.
We have entered into production contracts with certain major OEMs, including General Motors LLC, or GM, to supply fabricated, multi-part thermal barriers for use in the battery system of its next-generation EVs.
Thermal Barrier Contract We are party to production contracts with GM, to supply fabricated, multi-part thermal barriers, or Barriers, for use in the battery system of its next-generation EVs, or Contracts.
Although there are several other new accounting pronouncements issued by the FASB, we do not believe any of these accounting pronouncements had or will have a material impact on our Consolidated Financial Statements. We believe that the impact of recently issued accounting standards that are not yet effective will not have a material impact on our consolidated financial statements.
Although there are several other new accounting pronouncements issued by the FASB, we do not believe any of these accounting pronouncements had or will have a material impact on our Consolidated Financial Statements. Critical Accounting Policies and Estimates Our financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.
We plan to fund the capital expenditures required to build a carbon aerogel battery materials facility, and to construct a new aerogel blanket manufacturing facility with additional equity financings, debt financings, equipment leasing, sale-leaseback transactions, customer prepayments, government grant and loan programs or credit facilities.
We plan to fund the capital expenditures required to build a carbon aerogel battery materials facility, with additional equity financings, debt financings, equipment leasing, sale-leaseback transactions, customer prepayments, government grant and loan programs or credit facilities. Contractual Obligations and Commitments Operating Leases We lease office space for our corporate offices in Northborough, Massachusetts, which expires in 2031.
Material costs as a percentage of product revenue vary from product to product due to differences in average selling prices, material requirements, product thicknesses, and manufacturing yields.
Material costs as a percentage of product revenue were 38%, 36% and 51% for the years ended December 31, 2024, 2023 and 2022, respectively. Material costs as a percentage of product revenue vary from product to product due to differences in average selling prices, material requirements, product thicknesses, and manufacturing yields.
The increase in total revenue was the result of increases in both energy industrial and thermal barrier revenue. Energy industrial revenue increased by $9.8 million, or 9%, to $124.8 million in 2022 from $115.0 million in 2021.
The increase in total revenue was the result of increases in both energy industrial and thermal barrier revenue. Energy industrial revenue increased by $17.3 million, or 13%, to $145.9 million in 2024 from $128.6 million in 2023.
We expect that manufacturing expense will increase in absolute dollars and decrease as a percentage of revenue during 2024 due to increased staffing and spending levels in support of our thermal barrier business, including the operation of an automated fabrication facility in Monterrey, Mexico.
We expect that manufacturing expense will remain relatively flat in absolute dollars, due to ongoing cost reduction efforts, and increase as a percentage of revenue during 2025 due to lower expected revenues from the thermal barrier business, including the operation of an automated fabrication facility in Monterrey, Mexico.
Investing Activities Net cash used in investing activities is for capital expenditures for machinery and equipment principally to improve the throughput, efficiency and capacity of our East Providence facility, our automated fabrication facility in Mexico and engineering designs for the planned aerogel manufacturing facility in Bulloch County, Georgia.
This decrease in the use of cash was the result of the decrease in net loss adjusted for non-cash items of $44.8 million, and a decrease in cash used by changes in working capital of $7.0 million. 79 Investing Activities Net cash used in investing activities is for capital expenditures for machinery and equipment principally to improve the throughput, efficiency and capacity of our East Providence facility, our automated fabrication facility in Mexico and engineering designs for the planned aerogel manufacturing facility in Statesboro, Georgia.
The decrease in product volume had the effect of decreasing product revenue by approximately $6.6 million for the year ended December 31, 2022. Thermal barrier revenue was $55.6 million for the year ended December 31, 2022, as compared to $6.7 million for the year ended December 31, 2021.
The increase in product volume had the effect of increasing product revenue by approximately $0.7 million for the year ended December 31, 2024. Thermal barrier revenue was $306.8 million for the year ended December 31, 2024, as compared to $110.1 million for the year ended December 31, 2023.
The increase was the result of increases in depreciation and facility related expenses of $2.9 million and compensation and related costs of $2.1 million, partially offset by a decrease in operating material and supplies costs of $0.8 million. 74 Sales and marketing expenses as a percentage of total revenue decreased to 14% in 2023 from 16% in 2022 primarily due to the 32% increase in revenue from the comparable period in 2022.
The increase was the result of increases in depreciation and facility related expenses of $2.9 million and compensation and related costs of $2.1 million, partially offset by a decrease in operating material and supplies costs of $0.8 million.
Liquidity and Capital Resources Overview We have experienced significant losses and invested substantial resources since our inception to develop, commercialize and protect our aerogel technology and to build a manufacturing infrastructure capable of supplying aerogel products at the volumes and costs required by our customers.
The $6.9 million increase was the result of $4.9 million of interest income, $2.2 million of Employee Retention Credits and a $(0.2) million net impact of capitalized interest relating to our Convertible Note in the comparable period in 2022. 77 Liquidity and Capital Resources Overview We have experienced significant losses and invested substantial resources since our inception to develop, commercialize and protect our aerogel technology and to build a manufacturing infrastructure capable of supplying aerogel products at the volumes and costs required by our customers.
These expenses also include testing services, prototype expenses, consulting services, trial formulations for new products, equipment depreciation, facilities costs and related overhead. We expense research and development costs as incurred. We expect to continue to devote substantial resources to the development of new aerogel technologies, including our carbon aerogel battery materials.
Research and Development Expenses Research and development expenses consist primarily of expenses for personnel engaged in the development of next generation aerogel compositions, form factors and manufacturing technologies. These expenses also include testing services, prototype expenses, consulting services, trial formulations for new products, equipment depreciation, facilities costs and related overhead. We expense research and development costs as incurred.
We may, from time to time, enter into leasing arrangements including sale and leaseback financing arrangements. In January 2024, we entered into a sale and leaseback arrangement, pursuant to which we sold certain equipment to the Leasing Company for a one-time cash payment of $5.0 million and leased back such equipment from the Leasing Company.
In January 2024 and September 2024, we entered into sale and leaseback arrangements, pursuant to which we sold certain equipment to an equipment leasing company for one-time cash payments of $5.0 million and $10.0 million, respectively, and leased back such equipment from the leasing company. The associated monthly lease rents will be paid over the lease term of three years.
We believe that these investments are necessary to maintain and improve our competitive position. We also expect to continue to invest in research and engineering personnel and the infrastructure required in support of their efforts. We expect our research and development expenses will increase in absolute dollars and decrease as a percentage of revenue in 2024 and the longer term.
We expect to continue to devote substantial resources to the development of new aerogel technologies, including our carbon aerogel battery materials. We believe that these investments are necessary to maintain and improve our competitive position. We also expect to continue to invest in research and engineering personnel and the infrastructure required in support of their efforts.
The increase was the result of increases in compensation and related costs of $7.2 million, operating material and supplies costs of $1.8 million, travel related costs of $1.6 million, marketing costs of $0.8 million and professional fees and other expenses of $0.8 million.
The increase was the result of increases in depreciation and facility related expenses of $0.7 million, travel related expenses of $0.7 million, compensation and related costs of $0.6 million, utilities expenses of $0.4 million, and other expenses of $0.3 million.
Sales and marketing expenses as a percentage of total revenue increased to 16% in 2022 from 14% in 2021 primarily due to elevated levels of compensation associated with an increase in sales and marketing personnel.
Sales and marketing expenses as a percentage of total revenue decreased to 14% in 2023 from 16% in 2022 primarily due to the 32% increase in revenue from the comparable period in 2022.
Sales and Marketing Expenses Year Ended December 31, Change 2022 2021 Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage ($ in thousands) Sales and marketing expenses $ 28,792 16% $ 16,581 14% $ 12,211 74% Sales and marketing expenses increased by $12.2 million, or 74%, to $28.8 million in 2022 from $16.6 million in 2021.
Sales and Marketing Expenses Year Ended December 31, Change 2024 2023 Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage ($ in thousands) Sales and marketing expenses $ 35,677 8% $ 33,008 14% $ 2,669 8% Sales and marketing expenses increased by $2.7 million, or 8%, to $35.7 million in 2024 from $33.0 million in 2023.
At December 31, 2023, we had $358.9 million of net operating losses available to offset future federal income tax, if any, of which $194.6 million expire on various dates through December 31, 2038.
We record tax expenses in connection with our Mexican maquiladora operations. At December 31, 2024, we had $315.3 million of net operating losses available to offset future federal income tax, if any, of which $156.3 million expire on various dates through December 31, 2037.
Energy industrial revenue for the years ended December 31, 2022 and 2021, included $39.3 million and $34.1 million in sales to Distribution International, Inc., respectively.
Energy industrial revenue for the years ended December 31, 2024 and 2023, included $28.8 million and $33.6 million in sales to Distribution, respectively.
GAAP measure, to Adjusted EBITDA for the quarters presented: Three Months Ended Three Months Ended 2023 2022 March 31 June 30 Sept. 30 Dec. 31 March 31 June 30 Sept. 30 Dec. 31 ($ in thousands) Net loss $ (16,796 ) $ (15,423 ) $ (13,073 ) $ (519 ) $ (19,484 ) $ (24,050 ) $ (29,595 ) $ (9,609 ) Depreciation and amortization 2,704 3,503 4,550 4,561 2,129 2,032 2,531 2,530 Stock-based compensation (1) 2,267 2,710 2,789 3,188 1,828 2,295 2,590 2,672 Other (income) expense (2,112 ) (1,621 ) (1,561 ) 1,902 860 1,404 1,286 (57 ) Adjusted EBITDA $ (13,937 ) $ (10,831 ) $ (7,295 ) $ 9,132 $ (14,667 ) $ (18,319 ) $ (23,188 ) $ (4,464 ) (1) Represents non-cash stock-based compensation related to vesting and modifications of stock option grants, vesting of restricted stock units and vesting and modification of restricted common stock.
GAAP measure, to Adjusted EBITDA for the quarters presented: Three Months Ended Three Months Ended 2024 2023 March 31 June 30 Sept. 30 Dec. 31 March 31 June 30 Sept. 30 Dec. 31 ($ in thousands) Net income (loss) $ (1,835 ) $ 16,818 $ (12,970 ) $ 11,362 $ (16,796 ) $ (15,423 ) $ (13,073 ) $ (519 ) Depreciation and amortization 5,786 5,986 5,321 5,433 2,704 3,503 4,550 4,561 Stock-based compensation (1) 4,706 2,971 2,630 2,548 2,267 2,710 2,789 3,188 Other (income) expense 3,515 2,302 2,616 3,526 (2,112 ) (1,621 ) (1,561 ) 1,902 Loss on extinguishment of debt — — 27,487 — — — — — Income tax expense 756 866 267 (175 ) — — — — Adjusted EBITDA $ 12,928 $ 28,943 $ 25,351 $ 22,694 $ (13,937 ) $ (10,831 ) $ (7,295 ) $ 9,132 (1) Represents non-cash stock-based compensation related to vesting and modifications of stock option grants, vesting of restricted stock units and vesting and modification of restricted common stock.
Our PyroThin product is an ultra-thin, lightweight and flexible thermal barrier designed with other functional layers to impede the propagation of thermal runaway across multiple lithium-ion battery system architectures. Our thermal barrier technology is designed to offer a unique combination of thermal management, mechanical performance and fire protection properties.
We have developed and are commercializing our proprietary line of PyroThin® aerogel thermal barriers for use in battery packs in EVs. Our PyroThin product is an ultra-thin, lightweight and flexible thermal barrier designed with other functional layers to impede the propagation of thermal runaway across multiple lithium-ion battery system architectures.
We conduct business across the globe and a substantial portion of our revenue is generated outside of the United States.
For each of the noted periods, there were no other customers that represented 10% or more of our total revenues. We conduct business across the globe and a substantial portion of our revenue is generated outside of the United States.
The increase in total cost of revenue was the result of an increases in thermal barrier and energy industrial cost of revenue. Energy industrial cost of revenue increased $5.5 million, or 5%, to $106.0 million from $100.5 million in the comparable period in 2021.
The increase in total cost of revenue was the result of an increase in thermal barrier, offset, in part, by a decrease in energy industrial cost of revenue. Energy industrial cost of revenue decreased $7.1 million, or 7%, to $87.4 million from $94.5 million in the comparable period in 2023.
Products Our core businesses are organized into two reportable segments: Energy Industrial and Thermal Barrier. The following describes our key product offerings and new product innovations by reportable segment. Energy Industrial We design, develop and manufacture innovative, high-performance aerogel insulation used primarily in the energy industrial and sustainable insulation materials markets.
Products Our core businesses are organized into two reportable segments: Thermal Barrier and Energy Industrial. The following describes our key product offerings and new product innovations by reportable segment. Thermal Barrier We are actively developing a number of promising aerogel products and technologies for the electric vehicle (EV) market.
The $58.2 million increase was the result of a $17.0 million increase in material costs and a $41.2 million increase in manufacturing costs. The increase in material costs was the result of the increase in revenue volume from the comparable period in 2021.
The $7.1 million decrease was the result of a $20.1 million decrease in manufacturing and other operating costs and a $13.0 million increase in material costs from the comparable period in 2023.
The increase in total cost of revenue was principally driven by the increase in overhead costs and additional resources to support our expected higher run-rate revenue in future periods for both our energy industrial and thermal barrier products. 77 Research and Development Expenses Year Ended December 31, Change 2022 2021 Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage ($ in thousands) Research and development expenses $ 16,930 9% $ 11,441 9% $ 5,489 48% Research and development expenses increased by $5.5 million, or 48%, to $16.9 million in 2022 from $11.4 million in 2021.
The increase in total cost of revenue was principally driven by the increase in material costs due to higher volume and overhead costs and additional resources to support our expected higher run-rate revenue in future periods for both our energy industrial and thermal barrier products.
See “ Risk Factors - Risks Related to Our Business and Strategy - We will require significant additional capital to pursue our growth strategy, but we may not be able to obtain additional financing on acceptable terms or at all ” in this Annual Report on Form 10-K for the year ended December 31, 2022. 80 Analysis of Cash Flow The following table summarizes our cash flows for the periods indicated: Year Ended December 31, 2023 2022 2021 ($ in thousands) Net cash provided by (used in): Operating activities $ (42,612 ) $ (94,399 ) $ (18,628 ) Investing activities (175,455 ) (177,974 ) (13,778 ) Financing activities 75,477 478,370 92,474 Net increase (decrease) in cash (142,590 ) 205,997 60,068 Cash and cash equivalents, beginning of period 282,561 76,564 16,496 Cash and cash equivalents, end of period $ 139,971 $ 282,561 $ 76,564 Operating Activities During 2023, we used $42.6 million in net cash in operating activities, as compared to the use of $94.4 million in net cash during 2022, a decrease in the use of cash of $51.8 million.
Analysis of Cash Flow The following table summarizes our cash flows for the periods indicated: Year Ended December 31, 2024 2023 2022 ($ in thousands) Net cash provided by (used in): Operating activities $ 45,549 $ (42,612 ) $ (94,399 ) Investing activities (86,262 ) (175,455 ) (177,974 ) Financing activities 122,018 75,477 478,370 Net increase (decrease) in cash 81,305 (142,590 ) 205,997 Cash and cash equivalents, beginning of period 139,971 282,561 76,564 Cash and cash equivalents, end of period $ 221,276 $ 139,971 $ 282,561 Operating Activities During 2024, we provided $45.5 million in net cash from operating activities, as compared to the use of $42.6 million in net cash during 2023, a decrease in the use of cash of $88.2 million.
Cost of product revenue is recorded when the related product revenue is recognized. Material is a significant component of cost of product revenue and includes fibrous batting, silica materials and additives. Material costs as a percentage of product revenue were 36%, 51% and 48% for the years ended December 31, 2023, 2022 and 2021, respectively.
Cost of Revenue Cost of product revenue consists primarily of materials and manufacturing expense. Cost of product revenue is recorded when the related product revenue is recognized. Material is a significant component of cost of product revenue and includes fibrous batting, silica materials and additives.
A substantial majority of our revenue is generated from a limited number of direct customers, including distributors, contractors, fabricators, OEMs, partners and end-user customers.
We experienced a 90% increase in total revenue during 2024 driven by the increase in our energy industrial business, particularly in North America, and continued growth in the EV market. A substantial majority of our revenue is generated from a limited number of direct customers, including distributors, contractors, fabricators, OEMs, partners and end-user customers.